United States: Ninth Circuit Affirms Dismissal Of Putative Securities Class Action Against Biopharmaceutical Company Over Statements It Had Developed A COVID

United States: Ninth Circuit Affirms Dismissal Of Putative Securities Class Action Against Biopharmaceutical Company Over Statements It Had Developed A COVID "Cure" - Shearman & Sterling LLP

Mondaq

Published

The Company, a clinical-stage biopharmaceutical company, allegedly announced on May 15, 2020, that it had identified an antibody that demonstrated "100% inhibition" against the COVID-19 virus ...

Full Article